Schuyler Kevin 13D/13G Filings for Adial Pharmaceuticals, Inc. (ADIL)

Schuyler Kevin 13D and 13G filings for Adial Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-17
8:33 pm
Sale
2022-02-15 13D Adial Pharmaceuticals, Inc.
ADIL
Schuyler Kevin 44,251
4.570%
-13,608decrease
(-23.52%)
Filing